159 related articles for article (PubMed ID: 35763110)
1. N
Xu K; Dai X; Wu J; Wen K
J Cancer Res Clin Oncol; 2022 Dec; 148(12):3375-3384. PubMed ID: 35763110
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway.
Tong S; Wang X; Guo X; Lu Z
J Oral Pathol Med; 2022 Mar; 51(3):272-280. PubMed ID: 34637162
[TBL] [Abstract][Full Text] [Related]
3. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
4. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma.
Zhu X; Du J; Gu Z
Mol Cell Biochem; 2020 Nov; 474(1-2):147-158. PubMed ID: 32737775
[TBL] [Abstract][Full Text] [Related]
5. m
Xu L; Li Q; Wang Y; Wang L; Guo Y; Yang R; Zhao N; Ge N; Wang Y; Guo C
Am J Cancer Res; 2021; 11(11):5282-5298. PubMed ID: 34873461
[TBL] [Abstract][Full Text] [Related]
6. CLSPN actives Wnt/β-catenin signaling to facilitate glycolysis and cell proliferation in oral squamous cell carcinoma.
Hou Z; Wu C; Tang J; Liu S; Li L
Exp Cell Res; 2024 Feb; 435(2):113935. PubMed ID: 38237848
[TBL] [Abstract][Full Text] [Related]
7. LINC00958 regulated miR-627-5p/YBX2 axis to facilitate cell proliferation and migration in oral squamous cell carcinoma.
Chen F; Liu M; Yu Y; Sun Y; Li J; Hu W; Wang X; Tong D
Cancer Biol Ther; 2019; 20(9):1270-1280. PubMed ID: 31161900
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-143 suppresses oral squamous cell carcinoma cell growth, invasion and glucose metabolism through targeting hexokinase 2.
Sun X; Zhang L
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28174335
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA TFAP2A-AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR-1297 and regulating TFAP2A expression.
Yang K; Niu Y; Cui Z; Jin L; Peng S; Dong Z
Mol Carcinog; 2022 Sep; 61(9):865-875. PubMed ID: 35730908
[TBL] [Abstract][Full Text] [Related]
10. IGF2BP2 maybe a novel prognostic biomarker in oral squamous cell carcinoma.
Wang X; Xu H; Zhou Z; Guo S; Chen R
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35129592
[TBL] [Abstract][Full Text] [Related]
11. TIMELESS promotes reprogramming of glucose metabolism in oral squamous cell carcinoma.
Chen Y; Han Z; Zhang L; Gao C; Wei J; Yang X; Han Y; Li Y; Zhang C; Wei Y; Dong J; Xun W; Sun W; Zhang T; Zhang H; Chen J; Yuan P
J Transl Med; 2024 Jan; 22(1):21. PubMed ID: 38178094
[TBL] [Abstract][Full Text] [Related]
12. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
Han L; Cheng J; Li A
Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
[No Abstract] [Full Text] [Related]
13. CircZDBF2 up-regulates RNF145 by ceRNA model and recruits CEBPB to accelerate oral squamous cell carcinoma progression via NFκB signaling pathway.
Rong L; Chen B; Liu K; Liu B; He X; Liu J; Li J; He M; Zhu L; Liu K; Shi X; Shuai Y; Jin L
J Transl Med; 2022 Apr; 20(1):148. PubMed ID: 35365168
[TBL] [Abstract][Full Text] [Related]
14. m
Cui Y; Liu J; Liu L; Ma X; Gui Y; Liu H; Zhao W
Cancer Gene Ther; 2023 Jan; 30(1):163-171. PubMed ID: 36127411
[TBL] [Abstract][Full Text] [Related]
15. Circular
Zou C; Li X; Wei H; Wu S; Song J; Tang Z; Luo H; Lv X; Ai Y
Bioengineered; 2022 Apr; 13(4):11012-11025. PubMed ID: 35481460
[TBL] [Abstract][Full Text] [Related]
16. LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression.
Niu X; Yang B; Liu F; Fang Q
Biomed Pharmacother; 2020 Jan; 121():109623. PubMed ID: 31731187
[TBL] [Abstract][Full Text] [Related]
17. The m6A reader IGF2BP2 promotes the progression of esophageal squamous cell carcinoma cells by increasing the stability of OCT4 mRNA.
Zhao R; Li T; Zhao X; Yang Z; Ma L; Wang X
Biochem Cell Biol; 2024 Apr; 102(2):169-178. PubMed ID: 37917979
[TBL] [Abstract][Full Text] [Related]
18. Identification of RNA-splicing factor Lsm12 as a novel tumor-associated gene and a potent biomarker in Oral Squamous Cell Carcinoma (OSCC).
Dong Y; Xue L; Zhang Y; Liu C; Zhang Y; Jiang N; Ma X; Chen F; Li L; Yu L; Liu X; Shao S; Guan S; Zhang J; Xiao Q; Li H; Dong A; Huang L; Shi C; Wang Y; Fu M; Lv N; Zhan Q
J Exp Clin Cancer Res; 2022 Apr; 41(1):150. PubMed ID: 35449073
[TBL] [Abstract][Full Text] [Related]
19. N
Zhang Z; Xing Y; Gao W; Yang L; Shi J; Song W; Li T
Bioengineered; 2022 May; 13(5):11541-11550. PubMed ID: 35502827
[TBL] [Abstract][Full Text] [Related]
20. LncRNA DLEU1 facilitates the progression of oral squamous cell carcinoma by miR-126-5p/GAB1 axis.
Sun KD; Ni YJ; Qin H; Xu QF
Kaohsiung J Med Sci; 2022 Oct; 38(10):950-959. PubMed ID: 36039933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
